Return to homepagePandemic Pact

Clinicians and researchers from Metro North Hospital and Health Service (MNHHS)

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA148819

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2022

  • Known Financial Commitments (USD)

    $426,193.52

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Principal Investigator

    N/A

  • Research Location

    Australia, India

  • Lead Research Institution

    METRO NORTH HOSPITAL AND HEALTH SERVICE

  • Research Priority Alignment

    N/A

  • Research Category

    Infection prevention and control

  • Research Subcategory

    Barriers, PPE, environmental, animal and vector control measures

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Clinicians and researchers from Metro North Hospital and Health Service (MNHHS) and Queensland University of Technology (QUT), Australia will collaborate with researchers from Indian Institute of Science (IISc), India to generate novel Nanotextured materials that inactivate the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The Nanotextures will be fabricated on various materials using technologies such as hydrothermal processing and reactive-ion-etching in Australia and India. Exposure of virus to nanomaterials will be performed at QUT. The project is directed towards the delivery of antipathogenic nanomaterials for healthcare applications such as hospital environments and personal protection equipment.